Marcela V. Maus, M.D.,Ph.D. clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 0 with minor changes only.

1. Notable

   CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma

   Primary completion pushed from Jan 1, 2027 to Aug 1, 2027

   Also in this update: Completion pushed from Jan 1, 2028 to Aug 1, 2028

   Marcela V. Maus, M.D.,Ph.D.·Phase 1· NCT06026319· Registry history of NCT06026319 on ClinicalTrials.gov (opens the registry)

   Updated Oct 9, 2026

2. Notable

   Emapalumab Prevention of CAR-T Cell Associated Toxicities

   Primary completion pushed from Aug 1, 2026 to Aug 1, 2027

   Also in this update: Completion pushed from Aug 1, 2027 to Aug 1, 2028; Interventions modified

   Marcela V. Maus, M.D.,Ph.D.·Phase 2· NCT06550141· Registry history of NCT06550141 on ClinicalTrials.gov (opens the registry)

   Updated Oct 6, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.